Crizotinib is a tyrosine kinase inhibitor of ALK, MET, and ROS1 kinases.10 Commonly reported adverse effectsinclude nausea, vomiting, diarrhea, constipation, fatigue, transient visualdisorders, peripheral edema, and neutropenia. This evidence concerns the gene ALK and Decreased total neutrophil count.